https://www.appliedbiologics.com/news/ 2026-08-14T20:34:12+00:00 https://www.appliedbiologics.com/applied-biologics-presents-interim-campx-clinical-trial-data-at-the-symposium-on-advanced-wound-care-sawc-spring-2026/ 2026-06-10T17:01:24+00:00 https://www.appliedbiologics.com/applied-biologics-receives-fda-clearance-to-advance-bioxheal-into-phase-3-clinical-development-for-diabetic-foot-ulcers/ 2026-06-10T18:17:25+00:00 https://www.appliedbiologics.com/applied-biologics-launches-preclinical-development-program-focused-on-osteoarthritis-and-other-degenerative-diseases/ 2026-06-15T17:13:35+00:00 https://www.appliedbiologics.com/applied-biologics-reports-statistically-significant-improvement-in-wound-closure-outcomes-in-updated-analyses-of-the-campx-randomized-controlled-trial-evaluating-xwrap/ 2026-06-15T17:15:16+00:00 https://www.appliedbiologics.com/applied-biologics-announces-completion-of-planned-enrollment-activities-in-the-campx-randomized-controlled-trial-evaluating-xwrap/ 2026-06-18T20:05:36+00:00 https://www.appliedbiologics.com/applied-biologics-announces-submission-of-abstract-of-single-layer-amniotic-membrane-plus-standard-of-care-for-chronic-diabetic-foot-ulcers-an-updated-analysis-of-the-campx-trial-to-sawc-fall-2026/ 2026-06-23T17:45:00+00:00 https://www.appliedbiologics.com/applied-biologics-announces-completion-of-translational-research-supporting-the-biologic-performance-of-xwrap/ 2026-06-24T20:10:21+00:00 https://www.appliedbiologics.com/applied-biologics-announces-national-commercial-expansion-to-support-continued-growth-of-xwrap-and-future-biologic-product-pipeline/ 2026-07-01T19:37:33+00:00 https://www.appliedbiologics.com/applied-biologics-announces-expanded-strategic-focus-on-surgical-applications-of-xwrap/ 2026-07-01T19:39:34+00:00 https://www.appliedbiologics.com/applied-biologics-announces-successful-manufacture-of-first-research-construct-for-disease-modifying-osteoarthritis-gene-therapy-program/ 2026-07-17T17:01:52+00:00 https://www.appliedbiologics.com/applied-biologics-introduces-ecm-preservation-technology-as-the-proprietary-manufacturing-platform-behind-xwrap/ 2026-07-17T17:01:56+00:00 https://www.appliedbiologics.com/applied-biologics-announces-va-federal-supply-schedule-contract-modification-supporting-long-term-access-to-xwrap/ 2026-07-17T17:02:00+00:00 https://www.appliedbiologics.com/applied-biologics-announces-submission-of-xwrap-translational-research-abstract-for-consideration-at-sawc-fall-2026/ 2026-07-30T16:28:44+00:00 https://www.appliedbiologics.com/applied-biologics-initiates-multi-center-real-world-outcomes-study-of-xwrap-across-chronic-wound-types/ 2026-07-30T16:30:15+00:00 https://www.appliedbiologics.com/applied-biologics-announces-extension-of-longstanding-system-wide-agreement-with-providence-health-services-for-xwrap/ 2026-07-30T16:31:24+00:00 https://www.appliedbiologics.com/applied-biologics-expands-national-commercial-payer-engagement-strategy-for-xwrap/ 2026-07-30T16:32:25+00:00 https://www.appliedbiologics.com/applied-biologics-announces-successful-gmp-manufacturing-of-initial-clinical-lots-of-bioxheal/ 2026-07-30T16:33:23+00:00 https://www.appliedbiologics.com/applied-biologics-marks-10-years-of-continuous-aatb-accreditation-while-initiating-reaccreditation-process/ 2026-08-14T20:29:52+00:00 https://www.appliedbiologics.com/applied-biologics-receives-central-irb-approval-for-phase-3-bioxheal-clinical-trial/ 2026-08-14T20:31:13+00:00 https://www.appliedbiologics.com/cms-proposed-2027-medicare-policy-continues-recognition-of-the-fdas-section-351-biologic-pathway/ 2026-08-14T20:33:16+00:00 https://www.appliedbiologics.com/applied-biologics-launches-national-health-system-partnership-initiative/ 2026-08-14T20:34:12+00:00